Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piracetam augmentation of sertraline for major depressive disorder
IRCT20100119003106N37Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Sertraline + piracetam with Sertraline + placebo (2 arms). Primary endpoints: Change in depression severity, Change in serum interleukin-6 and 1 more. Started Sep 2017; status: completed.
02
Drugs
piracetamsertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20100119003106N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100119003106N37.